152 related articles for article (PubMed ID: 2509415)
1. In-vitro activity of meropenem against Neisseria gonorrhoeae, Haemophilus influenzae and H. ducreyi from Canada and Kenya.
Slaney L; Chubb H; Mohammed Z; Ronald A
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():183-6. PubMed ID: 2509415
[TBL] [Abstract][Full Text] [Related]
2. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
Powell M; Seetulsingh P; Williams JD
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206
[TBL] [Abstract][Full Text] [Related]
3. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains.
Miyazaki S; Fujikawa T; Kanazawa K; Yamaguchi K
J Antimicrob Chemother; 2001 Nov; 48(5):723-6. PubMed ID: 11679563
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
Visser MR; Hoepelman IM; Beumer H; Rozenberg-Arska M; Verhoef J
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1061-4. PubMed ID: 2695328
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain.
Kanazawa K; Nouda H; Sunagawa M
J Antibiot (Tokyo); 1997 Feb; 50(2):162-8. PubMed ID: 9099227
[TBL] [Abstract][Full Text] [Related]
7. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
Jorgensen JH; Maher LA; Howell AW
Antimicrob Agents Chemother; 1991 Mar; 35(3):600-2. PubMed ID: 2039214
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of meropenem against clinical isolates obtained in Canada.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
[TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.
King A; Boothman C; Phillips I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():31-45. PubMed ID: 2808214
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of meropenem in experimental meningitis.
Nairn K; Shepherd GL; Edwards JR
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():73-84. PubMed ID: 8543501
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis.
Fernández-Roblas R; López JC; Ramos JM; Gimeno M; Coronel P; Soriano F
J Antimicrob Chemother; 1996 May; 37(5):1038-9. PubMed ID: 8737159
[No Abstract] [Full Text] [Related]
13. Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.
Yourassowsky E; Van der Linden MP; Crokaert F
Chemotherapy; 1991; 37(1):38-42. PubMed ID: 2013240
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
Le Saux NM; Slaney LA; Plummer FA; Ronald AR; Brunham RC
Antimicrob Agents Chemother; 1987 Jul; 31(7):1153-4. PubMed ID: 2959199
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of imipenem against 100 strains of serotype b and nontypable Haemophilus influenzae, including strains resistant to ampicillin, chloramphenicol or both.
Campos JM; Gill CJ; Ahonkhai VI
J Antimicrob Chemother; 1985 Nov; 16(5):549-54. PubMed ID: 3878361
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
Piot P; Van Dyck E
Antimicrob Agents Chemother; 1982 Jan; 21(1):166-7. PubMed ID: 6805422
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi.
Ison CA; Dillon JA; Tapsall JW
Lancet; 1998; 351 Suppl 3():8-11. PubMed ID: 9652713
[No Abstract] [Full Text] [Related]
18. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
Slaney L; Chubb H; Ronald A; Brunham R
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of chloramphenicol and thiamphenicol against Haemophilus influenzae, Neisseria gonorrhoeae and the typhoid and paratyphoid bacilli.
Ng WS; Chau PY
Chemotherapy; 1982; 28(2):105-9. PubMed ID: 6804186
[TBL] [Abstract][Full Text] [Related]
20. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
